US Bancorp DE purchased a new stake in shares of Ardent Health Partners, LLC (NYSE:ARDT – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,834 shares of the company’s stock, valued at approximately $31,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. R Squared Ltd bought a new position in shares of Ardent Health Partners in the fourth quarter worth about $37,000. BNP Paribas Financial Markets purchased a new position in Ardent Health Partners in the 3rd quarter worth approximately $42,000. New York State Common Retirement Fund bought a new position in Ardent Health Partners in the 4th quarter worth approximately $48,000. MetLife Investment Management LLC purchased a new stake in Ardent Health Partners during the 3rd quarter valued at approximately $135,000. Finally, JPMorgan Chase & Co. bought a new stake in shares of Ardent Health Partners during the third quarter valued at approximately $154,000.
Ardent Health Partners Trading Up 1.1 %
NYSE ARDT opened at $14.24 on Wednesday. Ardent Health Partners, LLC has a one year low of $13.19 and a one year high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The company’s 50-day simple moving average is $14.67 and its two-hundred day simple moving average is $16.54.
Analysts Set New Price Targets
ARDT has been the subject of several research reports. JPMorgan Chase & Co. reissued a “neutral” rating and set a $20.00 price objective on shares of Ardent Health Partners in a report on Tuesday, December 17th. Morgan Stanley decreased their target price on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 21st. Stephens restated an “overweight” rating and set a $22.00 price target on shares of Ardent Health Partners in a report on Thursday, February 27th. Truist Financial reduced their price objective on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Royal Bank of Canada decreased their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 4th. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Ardent Health Partners currently has a consensus rating of “Buy” and a consensus price target of $21.18.
Get Our Latest Stock Report on Ardent Health Partners
About Ardent Health Partners
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Featured Stories
- Five stocks we like better than Ardent Health Partners
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- The Basics of Support and Resistance
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Short Nasdaq: An Easy-to-Follow Guide
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding ARDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ardent Health Partners, LLC (NYSE:ARDT – Free Report).
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.